Rahmouni, Souad ; Université de Liège - ULiège > GIGA > GIGA Medical Genomics - Unit of Animal Genomics ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques ; Université de Liège - ULiège > Unités de recherche interfacultaires > GIGA-Research
Georges, Michel ; Université de Liège - ULiège > GIGA ; Université de Liège - ULiège > GIGA > GIGA Medical Genomics - Unit of Animal Genomics ; Université de Liège - ULiège > Département de gestion vétérinaire des Ressources Animales (DRA) > GIGA-R : Génomique animale
Moutschen, Michel ; Centre Hospitalier Universitaire de Liège - CHU > > Service des maladies infectieuses - médecine interne ; Université de Liège - ULiège > GIGA > GIGA I3 - Immunology & Infectious Diseases ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R : Immunopathologie - Maladies infectieuses et médecine interne générale
Darcis, Gilles ; Centre Hospitalier Universitaire de Liège - CHU > > Service des maladies infectieuses - médecine interne ; Université de Liège - ULiège > Département des sciences cliniques ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R : Immunopathologie - Maladies infectieuses et médecine interne générale
Beguin, Yves ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique ; Université de Liège - ULiège > GIGA > GIGA I3 - Hematology
Language :
English
Title :
A second update on mapping the human genetic architecture of COVID-19.
COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature 600, 472–477 (2021). DOI: 10.1038/s41586-021-03767-x
COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19. Nature 608, E1–E10 (2022). DOI: 10.1038/s41586-022-04826-7
Kousathanas, A. et al. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature 607, 97–103 (2022). DOI: 10.1038/s41586-022-04576-6
Pairo-Castineira, E. et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature 617, 764–768 (2023).
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020). DOI: 10.1016/j.cell.2020.02.052
Vuille-dit-Bille, R. N. et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids 47, 693–705 (2015). DOI: 10.1007/s00726-014-1889-6
Tamayo-Velasco, Á. et al. ABO blood system and COVID-19 susceptibility: anti-A and anti-B antibodies are the key points. Front. Med. 9, 882477 (2022). DOI: 10.3389/fmed.2022.882477
Sorensen, G. L. Surfactant protein D in respiratory and non-respiratory diseases. Front. Med. 5, 18 (2018). DOI: 10.3389/fmed.2018.00018
Watson, A., Madsen, J. & Clark, H. W. SP-A and SP-D: dual functioning immune molecules with antiviral and immunomodulatory properties. Front. Immunol. 11, 622598 (2020). DOI: 10.3389/fimmu.2020.622598
Chatterjee, M., van Putten, J. P. M. & Strijbis, K. Defensive properties of mucin glycoproteins during respiratory infections-relevance for SARS-CoV-2. mBio 11, e02374-20 (2020). DOI: 10.1128/mBio.02374-20
van der Made, C. I. et al. Presence of genetic variants among young men with severe COVID-19. JAMA 324, 663 (2020). DOI: 10.1001/jama.2020.13719
Butler-Laporte, G. et al. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: results from the Host Genetics Initiative. PLoS Genet. 18, e1010367 (2022). DOI: 10.1371/journal.pgen.1010367
Namkoong, H. et al. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature 609, 754–760 (2022). DOI: 10.1038/s41586-022-05163-5
Chen, M.-H. et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell 182, 1198–1213 (2020). DOI: 10.1016/j.cell.2020.06.045
The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020). DOI: 10.1126/science.aaz1776
RECOVERY Collaborative Group. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet 400, 359–368 (2022). DOI: 10.1016/S0140-6736(22)01109-6
Shrine, N. et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat. Genet. 51, 481–493 (2019). DOI: 10.1038/s41588-018-0321-7
Fingerlin, T. E. et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 45, 613–620 (2013). DOI: 10.1038/ng.2609
Allen, R. J. et al. Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 201, 564–574 (2020). DOI: 10.1164/rccm.201905-1017OC
